|
1
|
Belakebi D, Godreuil S, Picot MC, Tribout V, Perrolaz C, Piccon L, Montoya A, Bistoquet M, Barnier Y, Picot É, Du-Thanh A. Response rate to intramuscular ceftriaxone 1 g in patients with gonococcal infection: A French monocentric prospective study. J Eur Acad Dermatol Venereol 2023; 37:e1229-e1231. [PMID: 37191202 DOI: 10.1111/jdv.19214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 05/10/2023] [Indexed: 05/17/2023]
Affiliation(s)
- Dorian Belakebi
- Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Sylvain Godreuil
- Department of Microbiology, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Marie-Christine Picot
- Unité de Recherche Clinique et Epidémiologie (Département Information Médicale), INSERM, Centre d'Investigation Clinique 1411, CHU Montpellier, Univ Montpellier, Montpellier, France
| | - Vincent Tribout
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Cyril Perrolaz
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Lisa Piccon
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Ana Montoya
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Marie Bistoquet
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Yannick Barnier
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Éric Picot
- Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France
- CeGIDD of Montpellier, Montpellier University Hospital and Montpellier University, Montpellier, France
| | - Aurélie Du-Thanh
- Department of Dermatology, Montpellier University Hospital and Montpellier University, Montpellier, France
- PCCEI, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France
| |
Collapse
|
|
2
|
Maubaret C, Caméléna F, Mrimèche M, Braille A, Liberge M, Mainardis M, Guillaume C, Noel F, Bébéar C, Molina JM, Lot F, Chazelle E, Berçot B. Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023. Euro Surveill 2023; 28:2300456. [PMID: 37707979 PMCID: PMC10687985 DOI: 10.2807/1560-7917.es.2023.28.37.2300456] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Accepted: 09/14/2023] [Indexed: 09/16/2023] Open
Abstract
We report two extensively drug-resistant (XDR) Neisseria gonorrhoeae (NG) isolates combining high-level resistance to azithromycin and resistance to ceftriaxone, obtained in France from two heterosexual patients, one of whom returned from Cambodia. Whole genome sequencing identified MLST ST16406, the mosaic penA-60.001 which caused ceftriaxone resistance in the internationally spreading FC428 clone, and the A2059G mutation in the 23S rRNA gene. The NG isolates F93 and F94 were related to XDR isolates detected in Austria and the United Kingdom in 2022.
Collapse
Affiliation(s)
- Clara Maubaret
- Paris Cité University, INSERM1137, IAME, Paris, France
- These authors contributed equally to this work and share first authorship
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | - François Caméléna
- Paris Cité University, INSERM1137, IAME, Paris, France
- These authors contributed equally to this work and share first authorship
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | - Manel Mrimèche
- Paris Cité University, INSERM1137, IAME, Paris, France
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | - Aymeric Braille
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | - Mathilde Liberge
- Paris Cité University, INSERM1137, IAME, Paris, France
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | - Mary Mainardis
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| | | | - Franck Noel
- Bioxa Laboratoire, Microbiology Laboratory, Bezannes, France
| | - Cécile Bébéar
- University of Bordeaux, USC EA 3671 Mycoplasmal and Chlamydial Infections in Humans, Bordeaux, France
- University Hospital, Bacteriology Department, French National Reference Centre for Bacterial STIs, Bordeaux France
| | - Jean-Michel Molina
- Paris Cité University, INSERM, UMR S976, Paris, France
- AP-HP, Infectious Disease Department, Saint Louis - Lariboisière Hospitals, Paris, France
| | - Florence Lot
- Santé publique France, the national public health agency, Saint-Maurice, France
| | - Emilie Chazelle
- Santé publique France, the national public health agency, Saint-Maurice, France
| | - Béatrice Berçot
- Paris Cité University, INSERM1137, IAME, Paris, France
- APHP, Infectious Agents Department, Saint Louis - Lariboisière University Hospitals, Paris, France
- French National Reference Centre for bacterial STI, Associated Laboratory for Gonococci, Paris, France
| |
Collapse
|
|
3
|
Mason LCE, Greig DR, Cowley LA, Partridge SR, Martinez E, Blackwell GA, Chong CE, De Silva PM, Bengtsson RJ, Draper JL, Ginn AN, Sandaradura I, Sim EM, Iredell JR, Sintchenko V, Ingle DJ, Howden BP, Lefèvre S, Njampeko E, Weill FX, Ceyssens PJ, Jenkins C, Baker KS. The evolution and international spread of extensively drug resistant Shigella sonnei. Nat Commun 2023; 14:1983. [PMID: 37031199 PMCID: PMC10082799 DOI: 10.1038/s41467-023-37672-w] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 03/24/2023] [Indexed: 04/10/2023] Open
Abstract
Shigella sonnei causes shigellosis, a severe gastrointestinal illness that is sexually transmissible among men who have sex with men (MSM). Multidrug resistance in S. sonnei is common including against World Health Organisation recommended treatment options, azithromycin, and ciprofloxacin. Recently, an MSM-associated outbreak of extended-spectrum β-lactamase producing, extensively drug resistant S. sonnei was reported in the United Kingdom. Here, we aimed to identify the genetic basis, evolutionary history, and international dissemination of the outbreak strain. Our genomic epidemiological analyses of 3,304 isolates from the United Kingdom, Australia, Belgium, France, and the United States of America revealed an internationally connected outbreak with a most recent common ancestor in 2018 carrying a low-fitness cost resistance plasmid, previously observed in travel associated sublineages of S. flexneri. Our results highlight the persistent threat of horizontally transmitted antimicrobial resistance and the value of continuing to work towards early and open international sharing of genomic surveillance data.
Collapse
Affiliation(s)
- Lewis C E Mason
- NIHR HPRU in Gastrointestinal Infections at University of Liverpool, Liverpool, UK
- Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK
| | - David R Greig
- Gastro and Food Safety (One Health) Division, UK Health Security Agency, London, UK
| | | | - Sally R Partridge
- Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia
- Western Sydney Local Health District, Westmead, NSW, Australia
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia
| | - Elena Martinez
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
| | - Grace A Blackwell
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
| | - Charlotte E Chong
- Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK
| | - P Malaka De Silva
- Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK
| | - Rebecca J Bengtsson
- Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK
| | - Jenny L Draper
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
| | - Andrew N Ginn
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
- Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia
| | - Indy Sandaradura
- Western Sydney Local Health District, Westmead, NSW, Australia
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
| | - Eby M Sim
- Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia
- Western Sydney Local Health District, Westmead, NSW, Australia
- Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia
| | - Jonathan R Iredell
- Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia
- Western Sydney Local Health District, Westmead, NSW, Australia
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia
| | - Vitali Sintchenko
- Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia
- Western Sydney Local Health District, Westmead, NSW, Australia
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
- Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia
- New South Wales Health Pathology, Dee Why, NSW, Australia
- Centre for Infectious Diseases and Microbiology - Public Health, Institute for Clinical Pathology and Microbiology Research, Westmead Hospital, Westmead, NSW, Australia
| | - Danielle J Ingle
- Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
| | - Benjamin P Howden
- Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
| | - Sophie Lefèvre
- Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France
| | - Elisabeth Njampeko
- Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France
| | - François-Xavier Weill
- Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France
| | | | - Claire Jenkins
- Gastro and Food Safety (One Health) Division, UK Health Security Agency, London, UK
| | - Kate S Baker
- NIHR HPRU in Gastrointestinal Infections at University of Liverpool, Liverpool, UK.
- Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK.
| |
Collapse
|